SCOPE: Epidemiological studies on the association between pregnancy outcomes and use of periconceptional folic acid are often based on maternal reported intake. Use of folic acid during pregnancy is associated with a higher socioeconomic status known to have an impact on diet quality. We have studied plasma B vitamin status according to reported use of folic acid supplements during the periconceptional period in Norwegian women. METHODS AND RESULTS: Plasma levels of folate, cobalamin, pyridoxal 5'-phosphate (vitamin B6), riboflavin, and the metabolic markers total homocysteine, methylmalonic acid and 3-hydro-xykynurenine were measured in pregnancy week 18 and related to reported intake of folic acid from 4 weeks prior to conception throughout week 18 in 2911 women from the Norwegian Mother and Child Cohort Study (MoBa) conducted by the Norwegian Institute of Public Health. Being a folic acid user during the periconceptional period was associated with a better socioeconomic status, and a higher intake of several micronutrients, including vitamins, trace-metals, and omega 3 fatty acids. Folic acid users had a significantly better plasma B vitamin status. CONCLUSION: Epidemiological data based on maternal reported intake of folic acid supplements during pregnancy, should take into account the numerous nutritional implications, in addition to higher blood folate levels, of being a folic acid user.
SCOPE: Epidemiological studies on the association between pregnancy outcomes and use of periconceptional folic acid are often based on maternal reported intake. Use of folic acid during pregnancy is associated with a higher socioeconomic status known to have an impact on diet quality. We have studied plasma B vitamin status according to reported use of folic acid supplements during the periconceptional period in Norwegian women. METHODS AND RESULTS: Plasma levels of folate, cobalamin, pyridoxal 5'-phosphate (vitamin B6), riboflavin, and the metabolic markers total homocysteine, methylmalonic acid and 3-hydro-xykynurenine were measured in pregnancy week 18 and related to reported intake of folic acid from 4 weeks prior to conception throughout week 18 in 2911 women from the Norwegian Mother and Child Cohort Study (MoBa) conducted by the Norwegian Institute of Public Health. Being a folic acid user during the periconceptional period was associated with a better socioeconomic status, and a higher intake of several micronutrients, including vitamins, trace-metals, and omega 3 fatty acids. Folic acid users had a significantly better plasma B vitamin status. CONCLUSION: Epidemiological data based on maternal reported intake of folic acid supplements during pregnancy, should take into account the numerous nutritional implications, in addition to higher blood folate levels, of being a folic acid user.
Authors: Philip Blumenshine; Susan Egerter; Colleen J Barclay; Catherine Cubbin; Paula A Braveman Journal: Am J Prev Med Date: 2010-09 Impact factor: 5.043
Authors: Arve Ulvik; Marta Ebbing; Steinar Hustad; Øivind Midttun; Ottar Nygård; Stein E Vollset; Kåre H Bønaa; Jan E Nordrehaug; Dennis W Nilsen; Henrik Schirmer; Per M Ueland Journal: Clin Chem Date: 2010-03-18 Impact factor: 8.327
Authors: R J Berry; Z Li; J D Erickson; S Li; C A Moore; H Wang; J Mulinare; P Zhao; L Y Wong; J Gindler; S X Hong; A Correa Journal: N Engl J Med Date: 1999-11-11 Impact factor: 91.245
Authors: Roy M Nilsen; Stein Emil Vollset; Anne Lise B Monsen; Arve Ulvik; Margaretha Haugen; Helle Margrete Meltzer; Per Magnus; Per Magne Ueland Journal: J Nutr Date: 2010-01-20 Impact factor: 4.798
Authors: Roy M Nilsen; Stein Emil Vollset; Håkon K Gjessing; Rolv Skjaerven; Kari K Melve; Patricia Schreuder; Elin R Alsaker; Kjell Haug; Anne Kjersti Daltveit; Per Magnus Journal: Paediatr Perinat Epidemiol Date: 2009-11 Impact factor: 3.980
Authors: Christine L Parr; Maria C Magnus; Øystein Karlstad; Margaretha Haugen; Helga Refsum; Per M Ueland; Adrian McCann; Per Nafstad; Siri E Håberg; Wenche Nystad; Stephanie J London Journal: Am J Respir Crit Care Med Date: 2017-01-15 Impact factor: 21.405